Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 56 Breast Neoplasms 49 Ovarian Neoplasms 31 Triple Negative Breast Neoplasms 27 Endometrial Neoplasms 25 Lung Neoplasms 24 Fallopian Tube Neoplasms 22 Neoplasm Metastasis 21 Squamous Cell Carcinoma of Head and Neck 19 Parkinson Disease 4, Autosomal Dominant Lewy Body 18 Neoplasms 14 Esophageal Squamous Cell Carcinoma 12 Esophageal Neoplasms 12 Carcinoma, Ovarian Epithelial 9 Stomach Neoplasms 8 Head and Neck Neoplasms 8 Colorectal Neoplasms 8 Carcinoma 7 Adenocarcinoma Of Esophagus 7 Peritoneal Neoplasms 6 Adenocarcinoma 6 Uterine Cervical Neoplasms 5 Melanoma 5 Oropharyngeal Neoplasms 4 Cholangiocarcinoma 4 Carcinoma, Transitional Cell 4 Small Cell Lung Carcinoma 3 Recurrence 3 Pancreatic Neoplasms 3 Mouth Neoplasms 3

Interventions

Paclitaxel 1 Nivolumab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancoast Syndrome × Paclitaxel × 90 days × Clear all

NCT05684276 2026-05-05

DUMAS

Fundación GECP

Phase 2 Active not recruiting

Pancoast Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡